OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
Both demand for and investment in fill/finish capacity continue to rise.
There are many benefits of employing a reformulation strategy, but companies must also overcome a variety of challenges too.
The industry revisits the pros and cons of microbial fermentation at scale for biotherapeutics.
BFS technology can help maintain sterility during the biologics manufacturing process.
A simplified downstream process can save time and costs but requires enabling technologies.
Using a minimum valuable product and process approach would make it is possible to discipline and structure the development of biopharmaceuticals in the fastest way possible.
Awareness of recently implemented—or ongoing—advances by the pharmacopoeias can help biotherapeutic manufacturers remain compliant with current requirements.
October 04, 2022
FDA has granted Fast Track designation for CUE-101, a treatment of recurrent/metastatic head and neck squamous cell carcinoma.
Pfizer has completed its acquisition of Biohaven Pharmaceuticals for approximately $11.6 billion.
October 02, 2022
October 01, 2022
Assessment of peripheral blood protein glycosylation has recently become scalable, providing a new domain for biomarker research.
Advances in Real-Time Supply Chain Operation Technology Can Address Drug Product Security Challenges
Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.